SCHEMBL901642

SCHEMBL901642

NCC(=O)O[C@H]1CCCCO1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
EPHX2 P34913 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA9 Q16790 2/20 0.31
CCNA2 P20248 1/20 0.31
CDK2 P24941 1/20 0.31
CCNA1 P78396 1/20 0.31
CDK5 Q00535 1/20 0.31
CDK5R1 Q15078 1/20 0.31
MGLL Q99685 1/20 0.30
TP53 P04637 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29271879 0.94 LMNA (0.39) MEN1KMT2ALMNAPOLBALDH1A1
SCHEMBL7999549 0.85 MEN1 (0.39) MEN1KMT2ALMNAPOLBEPHX2
SCHEMBL10805179 0.83 MEN1 (0.38) MEN1KMT2ALMNAPOLBEPHX2
SCHEMBL5521474 0.83 MEN1 (0.38) MEN1KMT2ALMNAPOLBEPHX2
SCHEMBL6299545 0.83 MEN1 (0.38) MEN1KMT2ALMNAPOLBEPHX2
SCHEMBL8750705 0.82 MGAM (0.38) MEN1KMT2ALMNAPOLBEPHX2
SCHEMBL5679436 0.81 LMNA (0.38) MEN1KMT2ALMNAPOLBALDH1A1
SCHEMBL20357987 0.81 CHRM2 (0.38) MEN1KMT2ALMNAPOLBEPHX2
SCHEMBL3812571 0.81 CHRM2 (0.38) MEN1KMT2ALMNAPOLBEPHX2
SCHEMBL3981084 0.81 MEN1 (0.38) MEN1KMT2ALMNAPOLBEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621931-A1 TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION Merck Sharp & Dohme Corp. (US) 2013-08-07 EP disclosed
WO-2012041014-A1 TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed